# CELLDEX THERAPEUTICS INC NEW (CLDX)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/CLDX/

- Reporting holders: 7
- Reported value: $7.5M
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Mirador Capital Partners LP](https://holderbook.com/funds/1633446-mirador-capital-partners-lp/) | $6.3M | 193,267 | 0.7% | 27 |
| [Apella Capital, LLC](https://holderbook.com/funds/1801507-apella-capital-llc/) | $811.2K | 26,658 | 0.0% | 7 |
| [Overbrook Management Corp](https://holderbook.com/funds/1269786-overbrook-management-corp/) | $373.9K | 11,537 | 0.1% | 5 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $22.6K | 697 | 0.0% | 11 |
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $22.3K | 689 | 0.0% | 7 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $9.3K | 287 | 0.0% | 15 |
| [MassMutual Private Wealth & Trust, FSB](https://holderbook.com/funds/1103653-massmutual-private-wealth-trust-fsb/) | $583 | 18 | 0.0% | 3 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 7 | $7.5M |
| Q2 2026 | 261 | $3.4B |
| Q1 2026 | 229 | $2.3B |
| Q4 2025 | 184 | $2.0B |
| Q3 2025 | 185 | $1.8B |
| Q2 2025 | 181 | $1.5B |
| Q1 2025 | 173 | $1.3B |
| Q4 2024 | 182 | $1.9B |
| Q3 2024 | 183 | $2.5B |
| Q2 2024 | 183 | $2.6B |
| Q1 2024 | 198 | $3.0B |
| Q4 2023 | 165 | $2.5B |